Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001140361-16-058182

Options or other derivatives

  • Sr VP & Chief Medical Officer acquired 85,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kowalski Mark · Sr VP & Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2016-03-15 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +85,000 85,000 D
Loading xslF345X03/doc1.xml…